Additionally, patients with diabetesregardless of medicationhave baseline increased UTI risk due to factors including impaired immune function, incomplete bladder emptying related to diabetic neuropathy, and historically elevated glucose levels that may have created favorable conditions for bacterial colonization
Those details are genuinely useful for due diligence, but they don't replace clinician review, pharmacy verification, or confirmation of current availability before you enroll
The STEP 1 trial, published in the New England Journal of Medicine, studied once-weekly semaglutide at 2.4mg in adults with overweight or obesity alongside lifestyle intervention
Users planning to stay on semaglutide long-term should treat protein targets as a permanent part of their routine
Reordered Henry Meds to #4 and Eden to #5
If maximum potency is your priority, injectable is the safer bet based on established pharmacology